Company: MVIS
Filing Date: 2025-02-03
Form Type: 424B5
Source: 0001493152-25-004622
Chunk: 11

Company: MICROVISION, INC.
Filing Date: 2025-02-03
Form: 424B5
Chunk 11
---
 September 30, 2024 and excludes, as of that date, the following:

| ● | 666,058                                                                                                  
 shares of our common stock issuable upon exercise of outstanding options, all of which  were exercisable 
 at a weighted average exercise price of $1.43 per share, under our Incentive Plan;                       |

| ● | 12,845,744                                                                   
 shares of our common stock underlying unvested and/or deferred stock awards; |

| ● | 2,784,660                                                                            
 shares of our common stock reserved for issuance pursuant to the Incentive Plan; and |
| ● | 5,750,225                                                                            
 shares of our common stock issuable upon exercise                                    
 of the warrants to be offered in this offering.                                      |

The number of shares outstanding shown above does not reflect any issuances of shares following September 30, 2024, including shares of our common stock issuable to High Trail Special Situations LLC upon exercise of that certain senior secured convertible note in the aggregate principal amount of $45,000,000 sold by us pursuant to the Securities Purchase Agreement dated October 14, 2024, in a private placement that we consummated on October 23, 2024.

| S-8 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We have agreed to sell directly to the investor all of the shares of common stock and warrants offered by this prospectus supplement. Other than WestPark Capital, Inc. and D. Boral Capital LLC, which are described below, no underwriters or agents were engaged by us for this transaction. We have entered into a securities purchase agreement directly with the investor in connection with this offering. The securities purchase agreement contains customary representations, warranties and covenants for transactions of this type. These representations, warranties and covenants were made solely for purposes of the securities purchase agreement and should not be relied upon by any of our investors who are not parties to the agreement, nor should any such investor rely upon any descriptions thereof as characterizations of the actual state of facts or condition. Such investors are not third party beneficiaries under the securities purchase agreement.

The purchase and sales under the securities purchase agreement (and the shares issuable upon exercise of the warrants) is registered pursuant to our shelf registration statement on Form S-3 File Number 333-272616 and as to which this prospectus supplement relates.

The foregoing description of the securities purchase agreement is only a summary, does not purport to be